BioPharm International, October 2011 Issue (PDF)
Examining the Outsourcing Relationship
Education and Training in Biopharmaceutical Development
It is important for all of us to be well versed in the new sciences that impact the development of protein therapeutics.
Trends in Biologics Outsourcing
A Q&A with Rick Hancock, president of Althea Technologies. This article contains bonus online material.
Survey Examines Trends in the Outsourcing Relationship
The BioPlan Associates 8th annual survey identifies key outsourcing concerns of sponsor companies.
Characterization of TrypZean: a Plant-Based Alternative to Bovine-Derived Trypsin (Peer-Reviewed)
An in-depth characterization of maize-derived trypsin revealed an unusual nonconsensus N-linked glycosylation.
Volatile Markets Take a Toll on Life-Sciences Initial Public Offerings
Contract Services Spending: Who's Spending What, and Where?
A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material.
Global Health Challenges Spur Vaccine Development
Manufacturers fund research and reduce prices to tackle diseases around the world.
Preparing for the Last War
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Perspectives in MicroRNA Therapeutics
The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.
How to Choose the Right CMO
Knowing in advance what you need can make a huge difference in a sponsor company's success.
